Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Elucidating the GREM1, HAS2 and PTGS2 Gene Expression as Oocytes Development Competency Markers Among Women With Poor Ovarian Reserve (POR) Following the in Vitro Maturation (IVM)

NCT06315777 is registered in ClinicalTrials.gov with National University of Malaysia as lead sponsor.

NCT NCT06315777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06315777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Elucidating the GREM1, HAS2 and PTGS2 Gene Expression as Oocytes Development Competency Markers Among Women With Poor Ovarian Reserve (POR) Following the in Vitro Maturation (IVM)
Lead sponsor
National University of Malaysia
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2021
Completion date
July 31, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cumulus cell, grem1 gene mutation, in vitro maturation, increased oocyte death